Combined intravenous treatment with ascorbic acid and desferrioxamine to reduce myocardial reperfusion injury in an experimental model resembling the clinical setting of primary PCI.

Chatziathanasiou, Georgios N; Nikas, Dimitrios N; Katsouras, Christos S; Kazakos, Nikolaos D; Bouba, Vasiliki; Vougiouklakis, Theodoros; Naka, Katerina K; Michalis, Lampros K

Chatziathanasiou, Georgios N; Nikas, Dimitrios N; Katsouras, Christos S; Kazakos, Nikolaos D; Bouba, Vasiliki; Vougiouklakis, Theodoros; Naka, Katerina K; Michalis, Lampros K.

Affiliation

Chatziathanasiou GN; Michaelideion Cardiac Center, Ioannina Medical School, Ioannina, Greece.

Hellenic J Cardiol ; 53(3): 195-204, 2012.

Article in En | MEDLINE | ID: mdl-22653244

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ascorbic Acid / Myocardial Reperfusion Injury / Coronary Vessels / Deferoxamine / Myocardial Infarction / Antioxidants Limits: Animals Language: En Journal: Hellenic J Cardiol Journal subject: CARDIOLOGIA Year: 2012 Document type: Article Affiliation country: Grecia Country of publication: Países Bajos

Search on Google

Add to My VHL

XML

PubMed Links